Research Article - (2021) Volume 0, Issue 0
Received: 26-Feb-2021
Published:
10-Mar-2021
, DOI: 10.37421/1747-0862.2021.s1.483
Citation: Orooji, Farideh, Sirous Naeimi and Mohammad Mehdi Moghani Bashi. “Association by Polymorphism of the IL22 Gene in Situations, rs867810424 (A/G) and rs1390124543 (A/G) with a Risk of Infertility in Women.” J Mol Genet Med 15(2021): S1-483.
Copyright: © 2021 Orooji F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Infertility is a growing and effective social disease in family relationships. The importance of controlling and measuring patient risk is determined by the individual's predisposing factors to infertility, genetic and acquired background. Inflammatory disorders are seen in many diseases, and cytokines, including IL22, play a role. IL22 is a precursor cytokine and has a dual role in are associated with increased egg fertility and the expansion of fatal growth. The aim of this study was to investigate the effect of two variants rs86781042 and rs1390124543 in IL22 on female infertility in southern Iran and compare it with healthy individuals. In this case study, evidence was used to study the polymorphism of the IL22 gene in the blood of 200 infertile and healthy patients in Shiraz hospitals, for DNA extraction and purification, using Salting Out and Proteinase K methods, followed by electrophoresis and PCR ARM was used. The results were analysed using SPSS software and Hardy Weinberg equilibrium. According to the results, it seems that the expression of two polymorphisms of IL22 gene is directly related to infertility in women in southern Iran and by using this relationship; it can be used as a biomarker for screening infertile women and diagnosing the disease.
IL 22 • rs867810424 • rs1390124543 • Infertility
Fertility is one of the great goals of creation for the survival of the generation, which is of particular importance [1]. Lack of fertility is very important in social and family issues and in many societies including Iran, childbearing is very important and plays a very important role in family survival and prevention of divorce [2]. The increase in infertility can be due to premature birth in couples, changes in sperm quality due to habits such as smoking, alcohol, and altered sexual behaviour. The prevalence of primary infertility in Iran is higher than the global trends in infertility and ovarian dysfunction is the major cause of primary infertility in Iran [3]. Lack of ovulation is a major problem for women, often with irregular menstruation. There are many factors that affect infertility in women. Some of these factors, such as age and genetic factors unfortunately do not change [4]. ISO immunization has been proven to be associated with infertility. Infertility is one of the most common chronic health disorders, regardless of age. The main infertility disorders include pathologic sperm grams, ovarian problems, tubal disease, pelvic adhesions/endometriosis, cervical and idiopathic factors. The molecular and cellular endometrial deficiency that leads to implantation failure can be associated with unknown infertility, as suppressing natural immunity does not preclude rejection of maternal immunity. Treg (T) cells are used to protect the fetus and maintain immunity against an immunosuppressive attack. A high percentage of infertile women are exposed to topical reactions leading to inflammation as well as high levels of anti-sperm serum antibodies. The anti-sperm antibody found in the mucus cervix has coagulant properties that peak in the luteal and follicular phases of the menstrual cycle; in contrast, it is low in ovulation. Mucosal immunity in the female reproductive system is affected by levels of natural and specific antibodies, cytokines and hormones [5]. Treg and Th17 cells play an important role in the regulation of immune regulation during pregnancy. During pregnancy, macrophages and dendritic cells are likely to support embryo acceptance in the uterus. IL10 secretion plays an important role in the regulation of immunity in decidua macrophages [6]. Estrogen helps proliferate endometrial immune cells. On the other hand, progesterone is also known to be a dominant regulator, since the greatest increase in endometrial immune cells is secreted when progesterone levels decrease. However, recognizing female organs and immune cells is crucial to the health of women and their successful pregnancies [7]. Factors due to chronic failure, such as pelvic adhesion, ovarian dysfunction, peritoneal deficiency, and endometrial variability, appear to be involved in infertility. Immune deficiency plays an important role in these cases [8]. The pathogenesis of infertility is associated with endometriosis with the involvement of biochemical, endocrine, immune, environmental and genetic factors. Immune cell types including macrophages and dendritic cells associated with inflammation are present in endometriosis and are likely to play a role in infertility associated with endometriosis [9]. Endometrium, serum, and peritoneal fluid in women with endometriosis have abnormal levels of inflammatory cytokines, angiogenic factors, growth factors, and adhesion. ILβ1 has a proliferative effect on endometrial cells, which does not occur in healthy endometrial cells [10]. ILβ1 stimulates the production of interleukins 6 and 8 in endometriosis cell culture, which further proliferates and reduces apoptosis. In addition, high levels of IL1β may cause the conversion of inflammation from acute to a chronic form [11]. Inherent immunity, in addition to adaptive immunity, plays an important role in pregnancy and NK cells are important in this process. Many signalling molecules and common pathways responsible for propagating an inflammatory response in somatic cells have been identified. Thus in the pregnant woman, the placenta as an organ enhances the ability of the immune cells to produce [12]. The concentration of IL19 and IL22 in the serum of patients with ovarian endometriosis is higher than that of women with uterine endometriosis [13]. Protein cytokines such as IL6, IL4, IL2, TNF-α and interferon-γ are increased in endometriosis and lead to increased inflammatory reactions. The inverse correlation between serum concentrations of interleukins and endometriosis activity suggests that anticoagulant cytokines, using a variety of biological effects, stimulate the desired immune system to promote ovarian endometriosis [14]. IL22 has a protective effect against autoimmune diseases and plays an important role in the development of various cancers such as lung, liver, etc [15]. IL22 is an IL10 family cytokine and is produced by Th17 cells, NKT cells. Initially, this cytokine targets epithelial cells and stroma of different tissues and plays a role in tissue proliferation and regeneration. Unlike many cytokines, the main effect of IL22 is on epithelial cells and fibroblasts in tissues such as the lung, liver, kidney, thyroid, pancreas, breast, intestine, skin and synovium, which have a profound effect on tissue regeneration. Post-injury epithelial mainly promotes survival by inducing proliferation and inhibiting apoptosis of epithelial cells [16]. Abnormal levels of IL22 and its receptors may be involved in the development of endometriosis. IL22 plays an important role in inflammation, immune surveillance and mucosal tissue homeostasis. It’s very high expression acts directly or indirectly as an inflammatory agent. Increased IL22 expression in ectopic lesions in women with endometriosis is probably due to pelvic inflammation [17]. IL22 is probably caused by endometrial estrogen and inflammation, stimulates tissue inflammation and regeneration, and, on the other hand, contributes to the formation of micro-environmental microenvironments in the ectopic form by stimulating the production of IL6, IL8 and VEGF participates. These integrated effects invade the endometrial vessel and contribute to the development and development of adenomyosis [18]. The imbalance of immune cells in the uterus and the dysfunction of their cytokines may lead to pregnancy loss [19]. Specific immune cells, which express different cytokines in relation to the mother and the fetus, are critical for the survival of early pregnancy [20]. Embryonic trophoblasts express the IL22R1 receptor and increase proliferation upon IL22 exposure. In spontaneous abortion samples IL22R1 expression was significantly lower than in normal pregnancies [21]. IL23 and IL17 are two cytokines that interact with IL22 in various systemic inflammatory conditions [22].
The purpose of this study was to investigate the IL22 and rs-867810424 and rs1390124543 polymorphisms in the risk of infertility in women.
In this study, the mean age of the patients was 32/23 ± 5/99 years and the mean age of the control group was 32/65 ± 6/23 the results of the PCR test led to the creation of fragments of the genome described in Materials and Methods section. Of the 200 infertile patients studied, 867810424 polymorphism showed GG (14%), AA (10%) and AG (75%). The frequency of genotypes in the control group were GG (7%), AA (3/5%) and AG (89/5%), respectively. Logistic regression and chi-square tests showed significant differences between patients and control group in all three genotypes (PV=0.001) (Tables 2 and 3).
P Chi- Square |
Sum of total samples |
Mis | AA | GG | AG | Study group |
---|---|---|---|---|---|---|
0/001 | 100% (200) | 1.0% (2) | 10% (20) | 14% (28) | 75% (150) | Patient |
100% (200) | 0% (0) | 3.5% (7) | 7% (14) | 89.5% (179) | rs867810424 | |
100% (400) | 0.5% (2) | 6.8% (27) | 10.5% (42) | 82.3% (329) | Control | |
0/005 | 100% (200) | 0.5% (1) | 17.5% (35) | 8.5% (17) | 73.5% (147) | rs867810424 |
100% (200) | 0% (0) | 8.1% (16) | 4.5% (9) | 87.5% (175) | Control rs1390124543 |
|
100% (400) | 0.3% (1) | 12.8% (51) | 6.5% (26) | 80.5% (322) | Total number of samples |
CI | OR | PV | Control | Patient | Study group rs867810424 |
---|---|---|---|---|---|
- | - | - | 7 | 20 | AA |
1/4 - 8//23 | Mar-41 | 0/004 | 179 | 150 | AG |
0/4 - 4//17 | 4-Jan | 0/5 | 14 | 28 | GG |
CI | OR | PV | Control | Patient | Study group rs1390124543 |
- | - | - | 8.0% (16) | 17.5% (35) | AA |
1/38- 4/89 | 6-Feb | 0/002 | 87.5% (175) | 73.5% (147) | AG |
0/4-3/1 | 1-Jan | 0/7 | 4.5% (9) | 8.5% (17) | GG |
In the variant rs1390124543 of the IL22 genes in the 200 patients studied, they showed GG genotype (8.5%), AA genotype (17.5%) and AG genotype (73.5%). In control group the frequency of genotypes were GG (4.5%), AA (8%) and AG genotype (87.5%) respectively. Statistical tests showed significant difference between patients and control group. All three genotypes were observed (PV=0/005) (Tables 2 and 3).
On the other hand, analysis of the IL22 alleles in polymorphism rs867810424 showed that 52% of the patients had G allele and 48% had Group A allele, which in the control group was 51.8% and 48.2%, respectively. (Pv=0/939). In the variant rs1390124543 this gene was also found in the patient group, 45.5% of the G allele and 54.5% of the A allele, and in the control group the frequency of alleles was 48.2% and 51.8%, respectively. (PV=0/433) (Table 4). The results were analysed by chi-square test and logistic regression analysis. There was no significant difference between the two alleles and infertility in both IL22 polymorphisms.
CI | OR | PChi- Square |
Sum of total samples | Allel A | Allel G | Study group |
---|---|---|---|---|---|---|
0/765 -1/335 | 1/011 | 0/939 | 100% (396) | 48% (190) | 52% (206) | Patient rs867810424 |
100% (400) | 48.2% (193) | 51.8% (207) | Control rs867810424 | |||
100% (796) | 48.1% (383) | 51.9% (413) | Total number of samples | |||
0/677 -1/182 | 0/898 | 0/433 | 100% (398) | 54.5% (217) | 45.5% (181) | Patient rs1390124543 |
100% (400) | 51.8% (207) | 48.2% (193) | Control rs1390124543 | |||
100% (798) | 53.1% (424) | 46.9% (374) | Total number of samples |
All clinical factors were significantly correlated with rs867810424 polymorphism, as their P Chi- Square was zero and less than 0/05. In this polymorphism, age and IUI were not associated with the disease, respectively, P=0/204 and P=0/223, respectively, and IVF, P=0/033, were significantly associated with the disease. In the rs1390124543 variant, age and IUI were not significantly correlated with infertility P=0/888 and P=0/734 respectively, and IVF P=0/092 was significantly associated with disease. All clinical factors were significant with this variant because PV=0.00 and less than 0.05 consequently, all clinical factors in these two polymorphisms of the IL22 gene can be effective in female infertility.
Infertility is a potentially serious, costly and burdensome problem for affected families. To accurately assess the prevalence of infertility using epidemiological studies, it is necessary to plan appropriately for prevention, treatment, management of infertility, its social and economic consequences [3]. During pregnancy, macrophages and dendritic cells support embryo acceptance in the uterus, and the number of interleukin-10 secretory cells in decidua macrophages is higher than peripheral blood monocytes [6]. This means that decidua macrophages play an important role in the regulation of immunity in the primordial uterus. Autoimmune-related infertility is a polyclonal event characterized by immunodeficiency at the Tcell surface and, like autoimmune diseases, produces abnormal antibody production [23]. Cytokines are protein molecules that are involved in acquired and innate immunity and regulate the immune response. Their effects stimulate the development and activation of the immune response or inhibit the appropriate response. Among these cytokines, IL22 is a pro inflammatory protein that is involved in the maintenance and regeneration of tissue and the inhibition of apoptosis [24]. IL22 function depends on the presence and relative amounts of other cytokines, the concentration and the presence of the sequestering agents [25]. The important role of this cytokine in inflammation is to monitor immune and tissue homeostasis and to increase its expression in endometriosis and non-malignant lesions [26]. Its high expression is either directly or indirectly as an inflammatory factor, and the increase in endometrial cytokines is directly "stimulated by inflammatory mediators, on the other hand, it enhances the proliferation and growth of uterine stromal cells that produce Ectopic endometriosis foci are ultimately associated with infertility [17]. IL22 has several single- or multi-nucleotide polymorphisms. There has been no study on the polymorphism of this cytokine in the indicated cases and infertility, but previous studies have suggested the role of this cytokine and other cytokines in some diseases. In a 2013 study by Wang et al., Researchers have shown that IL22 is involved in placental proliferation and that spontaneous miscarriage is more likely to occur if expression of this gene is reduced [22]. In a 2017 study by Sikora et al., The researchers concluded that interleukin-8 plays an important role in the development of endometriosis. Endometrial mesenchymal stem cells play an important role in the secretion of cytokines and endometriosis and ultimately infertility [27]. In a 2013 study, Santulli et al., concluded that decreased serum levels of interleukins 19 and 22 in women with endometrioma are associated with deep dyspareunia and chronic pelvic pain [28]. In a study by Wolk et al., the researchers examined the association of IL22 with various diseases and found that leukocyte-mediated IL22 was mainly targeted to tissue epithelial cells rather than immune cells. Which protects the tissue against attack by extracellular bacteria [29]. In a 2012 study, Paget et al., showed that IL22 protects bronchial epithelial cells from damage caused by influenza a virus [30]. In this study, we investigated the polymorphisms of 867810424rs and rs1390124543 of the IL22 gene and their association with infertility. According to the reviews, it seems that this is the first study and so far no study has been done. The results indicate that all three genotypes (GG, AA, AG) in both positions, in both patient and control groups with infertility showed a significant difference for alleles in both variants. Is not. Studies have shown that any mutations in the 5" - UTR region of the IL22 gene that lead to these two polymorphisms are likely to increase infertility in women.
In the present study, the frequency of IL22 genotypes in the patient and control groups was significant. 5”- UTR has become a gene promoter that will play a role in splicing and harvesting introns, As a result, the exons bind, complement, and segregate the target mRNA, eventually increasing the expression of the IL22 gene by lowering its serum levels in the body. In this case, this gene will act as a pro inflammatory factor in the development of inflammation and infertility. Thus, if both polymorphisms are present in the 5' IL22 gene, the risk of female infertility is increased. To better understand the mechanism of action of this cytokine in the development or resistance to infertility, it is recommended that further studies be carried out to investigate the expression level of this cytokine in patients and compare it with healthy controls and its association with the mentioned polymorphisms, to be paid.
This article is a thesis on the study of IL22 gene polymorphisms at positions rs867810424 (A/G) and rs1390124543 (A/G) in infertile women in south of Iran in 1398 with code: IR.IAU.KAU.REC.1398.008 The Islamic Azad University of Kazeroon Branch has been completed. This is a great tribute and appreciation to the Honourable Vice President of Research and Technology at Kazeroon Azad University.
No conflict of interest has been stated by the author.
Molecular and Genetic Medicine received 3919 citations as per Google Scholar report